S&P improves outlook on EXOR N.V.’s rating
S&P Global Ratings (S&P) communicated today that it has affirmed Exor’s long-term and short-term ratings (“BBB+” and “A-2” respectively) and it has improved the outlook to “positive” from “stable”.
Exor NV
Agreement signed for the sale to Exor of CIR’s 43.78% shareholding in GEDI
AGREEMENT SIGNED FOR THE SALE TO EXOR OF CIR’S 43.78% SHAREHOLDING IN GEDI, FOR €0.46 PER SHARE, REPRESENTING A TOTAL CONSIDERATION OF €102.4 MILLION
AFTER CLOSING, EXOR WILL LAUNCH A PUBLIC TENDER OFFER AT A PRICE OF €0.46 PER SHARE VIA A NEWCO
CIR INTENDS TO REINVEST IN THE NEW COMPANY IN ORDER TO RETAIN A 5% SHAREHOLDING IN GEDI
2019 Exor Investor Day
EXOR N.V. (MTA: EXO) will hold its 2019 Investor Day event tomorrow 21 November 2019 in Turin, Italy. The event will be hosted by Exor’s Chairman and CEO John Elkann, together with the Company’s leadership team. Attendance in person is by invitation only.
A live video webcast of the event will begin tomorrow at 3:00pm CET/ 2:00pm GMT / 9:00am EST. To access the webcast please refer to: livestream.com/ExorWebcast2019. Registration will be required.
EXOR announces the closing of its €300 million notes offering
EXOR N.V. announces today the settlement of the previously announced €300 million notes offering, priced on 7 October 2019 with a fixed annual coupon of 1.75% and due 14 October 2034.
The notes have been listed on the Luxembourg Stock Exchange for trading on the Euro MTF Market with a BBB+ credit rating assigned by Standard & Poor’s.
EXOR announces the pricing of €300 million notes maturing in 2034
EXOR announces today the pricing of €300 million notes due 14 October 2034, with an issue price of 99.725% and a fixed annual coupon of 1.75%. The notes will be listed on the Luxembourg Stock Exchange for trading on the Euro MTF Market with a BBB+ rating by Standard & Poor’s. The settlement of the issuance will take place on 14 October 2019. The purpose of the issuance is to raise new funds for EXOR’s general corporate purposes.
Exor’s Board of Directors approves H1 2019 consolidated results
The Exor Board of Directors’ meeting, chaired today by John Elkann, approved the consolidated results for the first half of 2019.
NAV
At 30 June 2019 Exor’s NAV (Net Asset Value) was $23,882 million, compared to $19,740 million at 31 December 2018. NAV per share was $101.06 at 30 June 2019, compared to $82.33 at 31 December 2018, an increase of $18.73/share (+22.8%). The change in NAV per share compared to the MSCI World Index in US$ is presented below: